Genetic: Polymorphism Analysis ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
49	Systemic lupus erythematosus	1
60	Aplastic anemia	1

49. Systemic lupus erythematosus

Clinical trials : 946 / Drugs : 722 - (DrugBank : 186) / Drug target genes : 117 - Drug target pathways : 199

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01060410 (ClinicalTrials.gov)	May 2010	1/2/2010	Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythe ...	Exploration of Genetic Polymorphisms Related to Individual Variations of Side Effects of Cyclophosph ...	Lupus Erythematosus, Systemic;Adverse Effects	Genetic: Polymorphism Analysis;Drug: Cyclophosphamide;Other: Pharmacokinetic analysis	Sun Yat-sen University	First Affiliated Hospital, Sun Yat-Sen University	Completed	12 Years	80 Years	Both	222	N/A	China

Clinical trials : 235 / Drugs : 381 - (DrugBank : 83) / Drug target genes : 44 - Drug target pathways : 160

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00343785 (ClinicalTrials.gov)	February 2006	22/6/2006	Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing ...	Cyclophosphamide and Antithymocyte Globulin Conditioning Regimen for Marrow Transplantation From HLA ...	Aplastic Anemia	Drug: cyclophosphamide;Biological: anti-thymocyte globulin;Drug: cyclosporine;Procedure: allogeneic ...	Fred Hutchinson Cancer Research Center	National Heart, Lung, and Blood Institute (NHLBI)	Completed	N/A	65 Years	All	21	Phase 2	United States;Canada